Marine Oil Market

Marine Oil Market Analysis and Forecast by Fact.MR

• The marine oil market is projected to grow from USD 2.3 billion in 2026 to USD 3.4 billion by 2036 at a 4.0% CAGR, supported by aquaculture feed enrichment demand.
• Growth is also supported by omega-3 supplement adoption and pharmaceutical interest in concentrated EPA and DHA formulations. Fish oil holds 48.3% product share.
• Dietary supplements contribute 52.8% application share as companies focus on purity standards, sustainable sourcing, and clinical-grade product development.

Summary of Marine Oil Market

• Market Snapshot
  • In 2025, the global Marine Oil Market was valued at approximately USD 2.2 billion.
  • The market is estimated to reach USD 2.3 billion in 2026 and is projected to attain USD 3.4 billion by 2036.
  • The marine oil market is likely to expand at a CAGR of 4.0% during the forecast period.
  • The market is anticipated to create an absolute dollar opportunity of USD 1.1 billion between 2026 and 2036.
  • Fish oil accounts for 48.3% of product segment share in 2026.
  • China (6.8%) and South Korea (6.3%) are the key growth markets during the forecast period.
• Demand and Growth Drivers
  • Growing clinical evidence supporting omega-3 fatty acids for cardiovascular, cognitive, and joint health is expanding consumer supplement demand globally.
  • Rising aquaculture production is increasing fish oil demand as a critical feed enrichment ingredient for salmon, shrimp, and other farmed species.
  • In addition to the regular dietary supplements, there is a premium demand segment for concentrated EPA and DHA formulations for pharmaceutical uses.
  • Development continues on molecular distillation and supercritical extraction technologies which improve oil purity and allow higher-concentration products.
  • Consumer demand for sustainably sourced marine ingredients is driving demand for certified and traceable fish oil and algae oil products.
• Product and Segment View
  • Fish oil is projected to account for 48.3% of product segment share in 2026 and will continue to lead due to its well-established role in supplements, aquafeed and functional foods.
  • Omega 3 rich marine oil leads composition with 57.6% share, reflecting the core demand for EPA and DHA across health, nutrition, and pharmaceutical applications.
  • Key segmentation includes:
    • Product: Fish Oil, Krill Oil, Algal Marine Oil, Calamari Oil, and Cod Liver Oil
    • Source: Wild Catch Marine Oil, Aquaculture Marine Oil
    • Use: Dietary Supplements, Pharmaceutical Industry, Food & Beverage Industry, and Aquaculture Industry
  • These products enable:
    • EPA and DHA in a concentrated form for nutritional and pharmaceutical use
    • Enrichment of feed for growth and nutrient balance of aquaculture species.
    • Addition of functional ingredients to foods and beverages
• Geography and Competitive Outlook
  • Asia Pacific dominates both production and consumption with large scale aquaculture and expanding supplement markets in China, South Korea and Japan.
  • Supplement-led demand in North America and Europe is solid, with the U.S. growing 5.9% CAGR driven by clinical adoption of omega-3 and pharma applications.
  • Through the production of anchovy-based fishmeal and oil, Latin American producers, especially Peru, remain an important source of supply for fish oil raw material.
  • Key players in the marine oil market include China Fishery Group Limited, Clover Corporation Ltd., GC Rieber VivoMega AS, Tecnológica de Alimentos S.A. / TASA, Pesquera Hayduk, Solutex GC, S.L. / Solutex, Evonik Industries, Pharma Marine, TripleNine, Olvea Group and Nissui Group.
• Analyst Opinion
  • Shambhu Nath Jha, Principal Consultant at Fact.MR, says "The marine oil market is being reshaped by two structural shifts: the expansion of pharmaceutical-grade omega-3 demand and the tightening of sustainability requirements across fish oil supply chains. Wild catch sourcing remains supply-constrained by fishing quotas, particularly from Peruvian anchoveta fisheries, while algae-based alternatives are scaling but still carry higher production costs. Companies that can secure certified supply, improve extraction purity, and build clinical validation for their omega-3 concentrates are positioned to capture premium pricing power."

Key Growth Drivers, Constraints, and Opportunities

Key Factors Driving Growth

• The supplement and pharmaceutical demand is being supported by the growing clinical evidence base for EPA and DHA benefits in cardiovascular, neurological and inflammatory conditions.
• As the production of farmed fish increases to meet global protein needs, the demand for aquaculture feed enrichment is increasing.
• Consumer preference for high-purity, molecularly distilled omega-3 products is driving premiumization across the supplement category.

Key Market Constraints

• The supply of wild catch is limited by fishing quota limits on Peruvian anchoveta and other pelagic species, which contribute to price volatility of raw materials.
• Marine oil processing, storage and distribution is expensive and complex because of sensitivity to oxidation and challenges managing shelf-life.
• The report also notes growing competition from algae-based and plant-based omega-3 alternatives, particularly among vegan and green consumer groups.

Key Opportunity Areas

• Prescription cardiovascular therapies using pharmaceutical-grade concentrated omega-3 formulations represent a high-value growth frontier.
• The development of marine oil from algae is diversifying supply away from reliance on fisheries.
• Emerging market expansion is expanding the addressable consumer base for Asia Pacific supplements and functional foods.

Segment-wise Analysis of the Marine Oil Market

• It is estimated that fish oil will hold 48.3% of the product segment in 2026 supported by well-established supply chains and broad application in supplements and aquafeed.
• Dietary Supplements lead with 52.8% application share in 2026, supported by consumer health awareness and clinical omega-3 demand.
• Molecular distillation leads the extraction technology market with a 37.4% share, reflecting the demand for high-purity refined products.

The market is segmented by product, source, extraction technology, application, composition, and region. Fish oil currently has the highest supply availability and cost, but algae oil is expected to catch up as production scales and vegan demand increases.

Which Product Segment Dominates the Marine Oil Market?

Fish oil accounts for 48.3% of the product segment value in 2026. Its leadership is based on a mature global supply chain, anchored by pelagic fisheries in Peru, Chile, Scandinavia and Southeast Asia. Fish oil is the main source of EPA and DHA for pharmaceutical raw materials, dietary supplements and aquaculture feed.

The main growth alternative is algae oil, a plant-based source of omega-3s that is not dependent on fisheries. Algae-based production is scaling up through companies such as Evonik (Veramaris joint venture) and DSM for aquafeed and vegan supplement applications.

Which Application Segment Dominates the Marine Oil Market?

Dietary supplements application segment value share in 2026 is 52.8%. This leadership is driven by consumer demand for omega-3 capsules, liquid supplements and fortified functional foods. The clinical interest in EPA and DHA for heart health, brain function and inflammation management is driving continued expansion.

The second largest use is in aquafeed, where fish oil is an important ingredient in the feed for salmon, shrimp and other farmed species. Pharmaceutical applications are smaller in volume but have the highest per unit value with concentrated EPA formulations used in prescription cardiovascular therapies.

Which Product Trend is Shaping the Next Phase of Growth in the Marine Oil Market?

Growing demand for concentrated and pharmaceutical-grade omega-3 formulations is the key driver of growth for the marine oil market. Standard fish oil capsules still represent the highest volume, but the value opportunity is moving toward high-purity EPA and DHA concentrates used in both premium supplements and prescription pharmaceuticals.

This trend is also supported by advances in molecular distillation and supercritical CO2 extraction that make it possible to achieve higher levels of concentration with a lower risk of contamination. Those companies who are investing in clinical validation and regulatory qualification for their concentrated products are positioning themselves to capture margins by multiples over that of normal supplement pricing.

Regional Outlook Across Key Markets

• China drives growth at 6.8% with expanding aquaculture production, growing supplement consumption and domestic marine oil processing capacity.
• South Korea at 6.3% and the U.S. at 5.9% reflect strong supplement-driven demand and clinical omega-3 adoption.
• European markets are up slightly, with the U.K. at 5.4% driven by pharmaceutical grade demand and Germany at 4.5% representing quality-oriented supplement shopping.

CAGR Table

Source: Fact.MR analysis, based on proprietary forecasting model and primary research.

Market Outlook for Marine Oil in China

The China Marine Oil Market is projected to grow at a CAGR of 6.8% through 2036. The scale of China's aquaculture industry and growing domestic supplement consumption are creating parallel demand channels for marine oil. Government support for self-sufficiency in marine resource processing and technology gap closure in extraction and refining capabilities are shaping the competitive landscape.

• Aquaculture feed demand from the largest global farmed fish production base sustains bulk fish oil consumption.
• Domestic marine oil processors are investing in molecular distillation capacity to serve growing supplement and pharmaceutical demand.
• Downstream pharmaceutical and personal care industries are creating new demand for refined marine oil ingredients.

South Korea Marine Oil Demand Trends

The South Korea Marine Oil Market is projected to grow at a CAGR of 6.3% through 2036. Demand is concentrated in the dietary supplement and functional food sectors, supported by South Korea's high consumer health awareness and established supplement distribution networks. The domestic preference for quality and clinical substantiation influences sourcing toward high-purity, certified marine oil products.

• Supplement manufacturers prioritize concentrated EPA and DHA formulations with clinical documentation for retail differentiation.
• Government R&D support for marine biotechnology strengthens domestic processing and product development capability.
• Functional food manufacturers are incorporating marine-derived omega-3 into consumer products beyond traditional supplement formats.

U.S. Marine Oil Market Growth Assessment

The U.S. Marine Oil Market is projected to grow at a CAGR of 5.9% through 2036. FDA regulatory pathways for omega-3 pharmaceutical products and the established clinical evidence base for EPA and DHA are supporting both supplement and prescription demand. The Inflation Reduction Act and broader healthcare cost management trends create indirect support for preventive health supplement adoption.

• Pharmaceutical-grade omega-3 concentrate demand continues to expand through FDA-approved cardiovascular therapies.
• Direct-to-consumer supplement brands are capturing share through subscription models and clinical marketing claims.
• Growing clinical evidence for EPA and DHA across cardiovascular and neurological applications supports continued category expansion.

United Kingdom Marine Oil Market Outlook

The U.K. Marine Oil Market is projected to grow at a CAGR of 5.4% through 2036. NICE health technology assessments and NHS procurement frameworks influence pharmaceutical-grade marine oil demand. Post-Brexit regulatory divergence is creating separate compliance requirements for marine oil supplements sold in the UK market.

• Pharmaceutical-grade omega-3 demand is supported by NHS preventive health guidelines.
• Supplement market maturity drives competition toward clinical differentiation and purity certification.
• Post-Brexit regulatory divergence is creating separate compliance requirements for marine oil supplements.

Germany Marine Oil Market Demand Analysis

The Germany Marine Oil Market is projected to grow at a CAGR of 4.5% through 2036. EU regulatory standards for supplement quality and DIN/EU performance requirements create a quality-oriented market. Energy cost pressures on domestic marine oil refining and processing influence sourcing strategies toward imported refined products.

• Strict quality and labeling requirements favor high-purity, independently tested marine oil supplements.
• Circular economy mandates influence packaging and waste management practices for supplement manufacturers.
• Pharmaceutical-grade marine oil products maintain strong positioning in German specialty health channels.

Competitive Benchmarking and Company Positioning

Marine Oil Market Analysis By Company

• China Fishery Group, Tecnológica de Alimentos S.A. / TASA, Pesquera Hayduk, and TripleNine hold strong supply-side positions through direct access to pelagic fisheries and integrated processing operations.
• Evonik Industries, Solutex GC, S.L. / Solutex, and Pharma Marine compete through extraction technology leadership and pharmaceutical-grade product capability.
• Nissui Group and GC Rieber VivoMega AS bridge supply and product innovation, with vertically integrated operations spanning raw material sourcing through refined product distribution.

The competitive landscape is fragmented across supply-oriented processors and technology-led refiners. China Fishery Group and the Peruvian producers (Tecnológica de Alimentos S.A. / TASA, Pesquera Hayduk, Pesquera Diamante) control significant raw material supply through fleet operations and processing plant networks. These companies compete on volume, cost efficiency, and fishery access.

Technology-led competitors such as Evonik, Solutex, and Pharma Marine differentiate through high-purity extraction, pharmaceutical qualification, and clinical validation capabilities. The growing pharmaceutical omega-3 segment rewards companies that invest in regulatory qualification and clinical evidence generation.

Key Companies in the Marine Oil Market

• China Fishery Group Limited, Tecnológica de Alimentos S.A. / TASA, Pesquera Hayduk, and TripleNine lead the supply side through fishery access, processing scale, and export distribution networks.
• Evonik Industries, GC Rieber VivoMega AS, Solutex GC, S.L. / Solutex, Pharma Marine, Clover Corporation Ltd., Nissui Group, Olvea Group, Arbee, Austral Group, Pesquera Diamante, Cellana Inc., and Mukka Proteins Limited compete across extraction technology, product specialization, and regional distribution.

Recent Industry Developments

• Pesquera Hayduk - Tambo de Mora Anchovy Processing Plant Acquisition (October 2025)
  • In October 2025, Pesquera Hayduk announced the acquisition of an anchovy processing plant in Tambo de Mora, Peru. The plant strengthens Hayduk’s integrated fish oil and premium fishmeal production network along the Peruvian coast.
• Nissui Group - EPA Pharmaceutical Raw Material Sales Expansion in Europe (2025)
  • In 2025, Nissui Group reported that EMA approval received in FY2024 enabled sales of EPA pharmaceutical raw materials in Europe. The update supports Nissui’s international expansion in high-purity fish-oil-derived pharmaceutical ingredients.
• EPAX - Evolve 05 VLC-PUFA Product Launch (April 2025)
  • In April 2025, EPAX launched EPAX Evolve 05, a marine-based omega-3 concentrate containing very long-chain polyunsaturated fatty acids. The launch expanded EPAX’s premium marine lipid portfolio for healthy aging and advanced omega-3 applications.

Key Companies in the Marine Oil Market

• Clover Corporation Ltd.
• Mukka Proteins Limited
• GC Rieber VivoMega AS
• Tecnológica de Alimentos S.A. / TASA
• Austral Group
• Pesquera Diamante
• Pesquera Hayduk
• Solutex GC, S.L. / Solutex
• Evonik Industries
• Pharma Marine
• TripleNine
• Olvea Group
• Nissui Group

Sources and Research References

• Food and Agriculture Organization of the United Nations. (2026). The state of world fisheries and aquaculture 2026.
• Global Organization for EPA and DHA Omega-3s. (2025, July 31). GOED publishes 2025 market report highlighting recovery and growth in the global EPA and DHA supply chain.
• IFFO, The Marine Ingredients Organisation. (2025, November 13). Global fishmeal and fish oil update.
• Nissui Corporation. (2025). Nissui Group integrated report 2025.
• Pesquera Hayduk. (2025, October). Hayduk strengthens its growth with the acquisition of a new plant in Tambo de Mora.
• National Institutes of Health, Office of Dietary Supplements. (2025, August 22). Omega-3 fatty acids: Health professional fact sheet.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

Key Questions This Report Addresses

• What is the estimated size of the global Marine Oil Market in 2026, and how is it projected to grow through the 2026 to 2036 forecast period?
• What incremental revenue opportunity is the Marine Oil Market expected to create between 2026 and 2036, and what CAGR underpins this projection?
• Which product segment is expected to hold the largest share in 2026, and what factors are supporting fish oil leadership over algae oil?
• How is the competitive balance between fish oil and algae-based marine oil expected to shift over the forecast period?
• Which application segment between dietary supplements and aquafeed is projected to generate the most incremental revenue through 2036?
• Which countries are projected to register the highest CAGR through 2036, and what country-specific factors are accelerating growth?
• How do demand patterns in Asia Pacific compare with those in North America and Europe in terms of application mix and growth drivers?
• What supply-side constraints, including fishing quota limits and raw material price volatility, could limit growth during the forecast period?
• What are the primary demand-side drivers sustaining growth, and how do they vary between supplement and pharmaceutical applications?
• Who are the leading companies, and how are they differentiating through sourcing, extraction technology, and clinical qualification?
• What recent strategic actions by key companies in 2025 and 2026 are reshaping competitive positioning in the marine oil market?
• Which extraction or product technology trend is driving the next phase of growth, and how is it changing buyer procurement requirements?
• How is the shift toward concentrated, pharmaceutical-grade omega-3 formulations influencing product development and pricing across the market?
• What role are sustainability certification and traceable sourcing playing in reshaping competitive dynamics and buyer procurement decisions?

Marine Oil Market Definition

The marine oil market covers oils derived from marine sources including fish, algae, and blended formulations, used across dietary supplement, aquaculture feed, pharmaceutical, and functional food applications. It includes both crude and refined marine oils in liquid, capsule, and powder formats.

Marine Oil Market Inclusions

• Global and regional market size and forecasts for 2026 to 2036 across product type, source, extraction technology, application, composition, and region.
• Demand analysis based on supplement consumption, aquaculture production, pharmaceutical R&D, and functional food formulation trends.
• Competitive landscape including company sourcing strategies, extraction capabilities, and distribution reach.

Marine Oil Market Exclusions

• Mineral oils, petroleum-derived marine lubricants, and non-biological marine oils.
• Plant-based omega-3 oils from flaxseed, chia, or hemp that are not marine-derived.
• Fishmeal products without oil extraction or marine oil content.

Marine Oil Market Research Methodology

• Methodology combines secondary research from trade publications, clinical databases, and fisheries data with primary validation.
• Draws on 90+ secondary sources and benchmarks 45+ company product portfolios.
• Market sizing for 30+ countries using inputs such as fishing quotas, aquaculture output, supplement sales data, and pharmaceutical demand.
• Primary validation is conducted through 20+ interviews across oil processors, supplement manufacturers, aquafeed producers and pharmaceutical buyers.